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Despite having a very low incidence of disease, reindeer (Rangifer tarandus) are subject to tuberculosis (TB)
testing requirements for interstate shipment and herd accreditation in the United States. Improved TB tests
are desperately needed, as many reindeer are falsely classified as reactors by current testing procedures. Sera
collected sequentially from 11 (experimentally) Mycobacterium bovis-infected reindeer and 4 noninfected rein-
deer were evaluated by enzyme-linked immunosorbent assay (ELISA), immunoblotting, and multiantigen print
immunoassay (MAPIA) for antibody specific to M. bovis antigens. Specific antibody was detected as early as 4
weeks after challenge with M. bovis. By MAPIA, sera were tested with 12 native and recombinant antigens,
which were used to coat nitrocellulose. All M. bovis-infected reindeer developed responses to MPB83 and a
fusion protein, Acr1/MPB83, and 9/11 had responses to MPB70. Other antigens less commonly recognized
included MPB59, ESAT-6, and CFP10. Administration of purified protein derivatives for skin testing boosted
serum antibody responses, as detected by each of the assays. Of the noninfected reindeer, 2/4 had responses
that were detectable immediately following skin testing, which correlated with pathological findings (i.e.,
presence of granulomatous lesions yet the absence of acid-fast bacteria). The levels of specific antibody
produced by infected reindeer appeared to be associated with disease progression but not with cell-mediated
immunity. These findings indicate that M. bovis infection of reindeer elicits an antibody response to multiple
antigens that can be boosted by skin testing. Serological tests using carefully selected specific antigens have
potential for early detection of infections in reindeer.
Mycobacterium bovis infection of reindeer (Rangifer taran-
dus) is rare, especially in North America, where there are no
published reports of the occurrence of tuberculosis (TB) in this
species. Despite the low incidence of disease, reindeer are
subject to regulations in the United States Department of
Agriculture (USDA) Bovine Tuberculosis Eradication Uniform
Methods and Rules (29), requiring testing for interstate move-
ment and herd accreditation. For TB surveillance of reindeer
within the United States, a single cervical test (a measure of
delayed-type hypersensitivity) is the primary test and the com-
parative cervical skin test (CCT) is used to confirm infection.
Although exact numbers are difficult to ascertain, many rein-
deer have tested positive by skin testing for TB surveillance.
Strains of Mycobacterium bovis or other Mycobacterium spp.
within the Mycobacterium tuberculosis complex, however, have
not been isolated from these reindeer upon necropsy. Reasons
for the high rate of false-positive reactions elicited by skin
testing are unclear, although it may be due to unusual exposure
to nontuberculous Mycobacterium spp. or an exaggerated cel-
lular immune response to mycobacterial antigens. Therefore,
improved TB tests are urgently needed to avoid the unneces-
sary slaughter of reindeer falsely identified as TB reactors.
For TB surveillance of captive wildlife (e.g., zoos or game
farms) and nontraditional livestock, blood-based TB assays are
appealing, as they require a single handling event, thereby
minimizing capture-associated injuries. Blood-based assays are
also more readily used in capture surveillance programs with
free-ranging wildlife (e.g., white-tailed deer [Odocoileus virgin-
ianus] in Michigan or Cape buffalo in Africa). While in vitro
cell-based assays appear promising, they require processing of
the blood sample within 24 h and are subject to complications
inherent with overnight delivery (e.g., temperature fluctuations
and delays in setup). For these reasons, serological tests are
particularly attractive for use in TB surveillance of nontradi-
tional livestock and wildlife. A major limiting factor for the
development of serological TB assays, particularly for rein-
deer, is the lack of specific information about antigens recog-
nized by antibodies that are produced during disease. Thus,
experimental M. bovis infection studies are necessary to char-
acterize the humoral immune response and to identify the
most reactive antigens that could be employed in serodiagnos-
tic tests.
Previous studies with cattle and white-tailed deer have re-
vealed both similarities and differences in the antibody re-
sponses against M. bovis infection of these two species (17, 18,
34). In particular, antigen recognition patterns appear to differ
from animal to animal in both species, and antibody levels are
significantly elevated shortly after the intradermal tuberculin
injection(s) for skin testing. Little, if anything, is known con-
cerning antibody responses of reindeer to M. bovis infection.
The present study describes the humoral response of rein-
* Corresponding author. Mailing address: United States Depart-
ment of Agriculture, Agricultural Research Service, National Animal
Disease Center, P.O. Box 70, Ames, IA 50010-0070. Phone: (515)
663-7756. Fax: (515) 663-7458. E-mail: rwaters@nadc.ars.usda.gov.
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deer to experimental infection with M. bovis. Specific objec-
tives were to determine (i) antigen recognition patterns by
serum antibodies, (ii) relationships of the humoral responses
with cell-mediated immunity and disease progression, (iii) the
effect of tuberculin skin testing on the antibody response, and
(iv) the potential for serological tests in TB surveillance pro-
grams for reindeer.
MATERIALS AND METHODS
Animals, challenge, and necropsy. Thirty-four castrated male reindeer (Ran-
gifer tarandus) of approximately 9 months of age were obtained from a TB-free
herd in Michigan and housed at the National Animal Disease Center, Ames,
Iowa, according to institutional guidelines and approved animal care and use
protocols. Eleven animals were experimentally infected with M. bovis, and four
animals were kept noninoculated as a control group. For M. bovis infection, the
challenge inoculum (105 CFU in 0.2 ml of phosphate buffered saline [PBS], pH
7.2) was instilled directly into the tonsillar crypts of anesthetized reindeer (n 
11) as described for the inoculation of white-tailed deer (21). The strain of M.
bovis used for the challenge inoculum (95-1315 [USDA, Animal Plant and
Health Inspection Service {APHIS} designation]) was originally isolated from a
white-tailed deer in Michigan (24). Inoculum consisted of mid-log-phase M. bovis
cells grown in Middlebrook’s 7H9 medium supplemented with 10% oleic acid-
albumin-dextrose complex (Difco, Detroit, Michigan) plus 0.05% Tween 80
(Sigma Chemical Co., St. Louis, Missouri). At the time of inoculation, reindeer
were moved from an outdoor pen into climate-controlled rooms (two to three
animals/room) within a biosafety level 3 confinement facility. Negative airflow
exited the building through HEPA filters, ensuring that air from animal pens was
pulled towards a central corridor and through HEPA filters before exiting the
building. The airflow velocity was 10.4 air changes/h. Four noninoculated rein-
deer were housed in a climate-controlled room in a building (biosafety level 2
facility) separate from the building in which the infected reindeer were housed.
Additionally, serum samples from 19 reindeer housed outdoors at the National
Animal Disease Center were obtained.
Thirteen months after inoculation, reindeer in the infected (n  11) and
noninoculated (n  4) groups were euthanized by an intravenous injection of
sodium pentobarbital (Fort Dodge Animal Health, Fort Dodge, Iowa) and ex-
amined. Various tissues were collected for bacteriologic culture and microscopic
examination. Detailed descriptions of cellular immune responses (35), bacterio-
logic culture, histopathology, and gross necropsy results are presented elsewhere
(23).
CCT. Ninety days after M. bovis inoculation, reindeer were tested for in vivo
responsiveness to mycobacterial antigens by a modified CCT technique enabling
the collection of biopsy specimens for which the dermal reactions to purified
protein derivatives (PPDs) at 24, 48, and 72 h postinjection could be analyzed
(23, 33). Briefly, the cervical region was clipped and animals injected intrader-
mally in three separate locations with M. bovis PPD and a single location with
Mycobacterium avium PPD (PPDs obtained from National Veterinary Services
Laboratory, Ames, Iowa). A standard CCT (i.e., single intradermal injection
each of M. avium PPD and M. bovis PPD) was performed 8 months after M. bovis
inoculation (22, 29). For each of the skin tests, 100 g of M. bovis PPD and 40
g of M. avium PPD were administered at each respective location according to
guidelines described in USDA, APHIS circular 91-45-011 (29). Skin thickness at
each injection site was measured prior to injection of PPDs and 72 h after
administration. Changes in skin thickness were calculated and responses plotted
on a scattergram developed by USDA for the interpretation of the CCT for
bison, cattle, and cervidae (Form VS-6-22D). Responses by individual reindeer
within both infected and noninfected groups are presented elsewhere (23).
Enzyme-linked immunosorbent assay (ELISA). Lipoarabinomannan (LAM)-
enriched mycobacterial antigen was prepared from M. bovis strain 95-1315 as
described previously (31). Briefly, bacilli harvested from 4-week cultures were
sonicated in PBS, further disrupted with 0.1- to 0.15-mm glass beads (Biospec
Products, Bartlesville, Oklahoma) in a bead beater (Biospec Products), centri-
fuged, filtered (0.22-m-pore-size filter), and digested in a 1-mg/ml proteinase K
(Roche Molecular Biochemicals, Indianapolis, Indiana) solution (50 mM Tris, 1
mM CaCl2 buffer, pH 8.0) for 1 h at 50°C. Protein concentrations were deter-
mined (Bio-Rad, Hercules, California) and antigen stored at 20°C.
Immulon II 96-well microtiter plates (Dynatech, Chantilly, Virginia) were
coated with 100 l/well (4 g) antigen diluted in carbonate/bicarbonate coating
buffer (pH 9.6). Antigen-coated plates, including control wells containing coating
buffer alone, were incubated for 15 h at 4°C. Plates were washed three times with
200 l/well PBS containing 0.05% Tween 20 (PBST) (Sigma), and blocked with
200 l/well of a commercial milk diluent/blocking solution (Kirkegaard and Perry
Laboratories, Gaithersburg, Maryland). After incubation for 1 h at 37°C in the
blocking solution, wells were washed nine times with 200 l/well PBST and test
sera added to wells (100 l/well). Test and control sera were diluted 1:100 in PBS
containing 0.1% gelatin. After incubation for 20 h at 4°C with diluted test sera,
wells were washed nine times with 200 l/well PBST and incubated for 1 h at
37°C with 100 l/well of biotin-protein G (Sigma) diluted 1:5,000 in PBS plus
0.1% gelatin. Wells were washed nine times with 200 l/well PBST and incubated
for 1 h at 37°C with 100 l/well of peroxidase-streptavidin (Sigma) diluted
1:2,000 in PBS plus 0.1% gelatin. Wells were washed nine times with 200 l/well
PBST and incubated for 4 min at room temperature with 100 l/well of SureBlue
3,3,5,5-tetramethyl benzidine nsrsid6847181\delrsid6847181\charrsid6847181
microwell peroxidase substrate (Kirkegaard and Perry Laboratories). The reac-
tion was stopped by the addition of 100 l/well of 0.18 M sulfuric acid and the
absorbances (450 nm) of individual wells measured using an automated ELISA
plate reader (Molecular Devices, Menlo Park, California). Data are presented as
the changes in optical density readings calculated by subtracting the mean optical
density readings for wells receiving coating buffer alone (two replicates) from the
mean optical density readings for antigen-coated wells (two replicates) receiving
the same serum sample.
Immunoblot assay. Electrophoresis and immunoblot assays were performed
using previously described procedures (2) with the following modifications. The
antigen for immunoblotting was a whole-cell sonicate (WCS) of M. bovis strain
95-1315. Following standard culture, mycobacteria were pelleted (10,000  g for
20 min) and washed twice with cold PBS. Pellets were resuspended in PBS and
sonicated on ice with a probe sonicator. Sonication consisted of three 10-min
bursts at 18 W on ice, with 10-min chilling periods between sonications. Debris
was removed by centrifugation (12,000 g for 5 min) and supernatants harvested
and stored at 20°C. Protein concentrations were determined by using a protein
assay (Bio-Rad, Richmond, CA). Comparisons of the reactivities of serial serum
samples against WCS antigen were conducted using a slot-blotting device (Bio-
Rad, Richmond, CA). Antigen (200 g) was electrophoresed through prepara-
tive 12% (wt/vol) polyacrylamide gels and transferred to nitrocellulose filters.
These filters were placed in a blocking solution consisting of PBST and 2%
(wt/vol) bovine serum albumin (PBST-BSA). After the blocking, the filters were
placed into the slot blot device, and individual sera, diluted 1:200 in PBST-BSA,
were added to independent slots. After a 2-h incubation with gentle rocking,
blots were washed three times with PBST and incubated with horseradish per-
oxidase-conjugated protein G (Sigma) diluted 1:40,000 in PBST-BSA for 1.5 h.
Blots were again washed three times with PBST and developed for chemilumi-
nescence in SuperSignal detection reagent (Pierce Chemical Co.).
Multiantigen print immunoassay (MAPIA). The following recombinant anti-
gens of M. bovis were purified to near homogeneity as polyhistidine-tagged
proteins (Rv numbers according to the classification of Cole et al. [3] in paren-
theses): ESAT-6 (Rv3875) and CFP10 (Rv3874) produced at the Statens Serum
Institut, Copenhagen, Denmark; MPB59 (Rv1886c), MPB64 (Rv1980c), MPB70
(Rv2875), and MPB83 (Rv2873) (produced at the Veterinary Sciences Division,
Stormont, Belfast [15]). Alpha-crystallin (Acr1) (Rv3391) and the 38-kDa pro-
tein PstS1 (Rv0934) were purchased from Standard Diagnostics, Seoul, South
Korea. Polyprotein fusions CFP10/ESAT-6 and Acr1/MPB83 were constructed
by overlapping PCR using gene-specific oligonucleotides to amplify the genes
from M. tuberculosis H37Rv chromosomal DNA. The fused polygene PCR prod-
ucts were cloned into the pMCT6 Escherichia coli expression vector by using
SmaI/BamHI restriction enzymes. The polyproteins were purified to near homo-
geneity by exploiting the polyhistidine tag encoded by the vector. M. bovis culture
filtrate (MBCF) was obtained from a field strain of M. bovis (T/91/1378; Veter-
inary Sciences Division, Belfast, United Kingdom) cultured in synthetic Sauton’s
medium. MAPIA was performed as described previously (19). Briefly, antigens
were immobilized on nitrocellulose membrane (Schleicher & Schuell, Keene,
NH) at a protein concentration of 0.05 mg/ml by using a semiautomated air-
brush-printing device (Linomat IV; Camag Scientific Inc., Wilmington, DE). The
membrane was cut, perpendicular to the antigen bands, into 4-mm-wide strips.
Strips were blocked for 1 h with 1% nonfat skim milk in PBS with 0.05% Tween
20 and then incubated for 1 h with serum samples diluted 1:40 in blocking
solution. After being washed, strips were incubated overnight with horseradish
peroxidase-conjugated protein G (Sigma, St. Louis, MO) diluted 1:1,000, fol-
lowed by another washing step. Deer antibodies bound to printed antigens were
visualized with 3,3,5,5-tetramethyl benzidine (Kirkegaard and Perry Laborato-
ries, Gaithersburg, MD).
Statistics. Data were analyzed by repeated measures (one-way analysis of
variance followed by a Tukey-Kramer multiple comparisons test, using a com-
mercially available statistics program [InStat 2.00; GraphPAD Software, San
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Diego, CA]). Pearson’s product-moment correlations between MAPIA and pa-
thology scores were computed.
RESULTS
Infection status. Inoculation of M. bovis into tonsillar crypts
of reindeer resulted in gross and microscopic lesions in all
inoculated animals (23). Tuberculous lesions were most prom-
inent in medial retropharyngeal lymph nodes and were also
detected in tonsils, mesenteric lymph nodes, lungs, and lung-
associated lymph nodes. Infected reindeer did not have clinical
signs of TB or disseminated disease after 1 year of coloniza-
tion, suggesting low-grade chronic infection. M. bovis cultures
were isolated from tissues of 6/11 infected animals but not
from control reindeer; however, granulomatous lesions with no
acid-fast bacteria were detected within the tracheobronchial
lymph nodes of 2/4 noninoculated reindeer (Table 1).
Serological response to LAM-enriched antigens and WCS.
Antibodies to M. bovis LAM were detected by ELISA in sera
taken 15 weeks after challenge with M. bovis, 2 weeks after the
injection of PPDs for skin testing (Fig. 1). By 22 weeks post-
challenge, responses to LAM had waned and were again
boosted upon the injection of PPDs for the second skin test.
The two noninoculated reindeer that had granulomatous le-
sions also had responses to M. bovis LAM that were detectable
after the skin test (Table 1).
By the immunoblotting of M. bovis WCS, responses by in-
fected reindeer were detected as early as 8 weeks postchal-
lenge (Fig. 2). Specific bands of reactivity at 15, 25, 32,
42, 75, and 100 kDa were detected. Responses were
boosted by the injection of PPDs for the skin test. As was the
case with the LAM ELISA, injection of PPDs for the skin test
elicited a response detectable by the immunoblotting of sam-
ples from two of the four noninoculated reindeer (animals 123
and 129), although the response was detectable only after the
second skin test for animal 123. Immunoblot responses (i.e.,
intensity and number of bands) by 10/11 infected reindeer
greatly exceeded the detected responses in samples from the
two responding noninoculated reindeer. The two noninocu-
lated reindeer had only a single, light band of reactivity at 25
kDa, whereas sera from infected reindeer elicited multiple,
heavy bands of reactivity upon immunoblotting.
Serological response to purified proteins. To further char-
acterize the humoral immune response, the MAPIA was used
to determine responses to a panel of recombinant M. tubercu-
losis/M. bovis proteins. Antigens recognized by sera from M.
FIG. 1. Response kinetics of serum antibody specific for LAM-enriched antigen. Sera from M. bovis-infected reindeer (■; n  11) were
analyzed for reactivity to M. bovis-derived LAM by ELISA. Data are presented as mean (	 standard errors of the mean) changes in optical density
(
OD). Arrows on the x axis indicate time points when purified protein derivatives were injected for skin testing (CCT). Asterisks (*) indicate
responses that exceed (P  0.05) preinfection responses (i.e., week 1).
TABLE 1. Comparison of pathologies and serologies from
noninoculated reindeer
Animal
ELISA antibody response
(
OD)a Pathologyb
Day 7 Post-CCT
123 0.021 0.891 g, m
124 0.626 0.023 —
129 0.066 0.478 g, m
132 0.023 0.013 —
a Change in optical density (
OD) (response to M. bovis-derived lipoarabino-
mannan-enriched antigen minus the response to no antigen) by sera from non-
inoculated reindeer at the initiation of the study (day 7) and 2 weeks after
injection of purified protein derivative for the initial comparative cervical test
(post-CCT) 16 weeks later.
b g, gross lesions consistent with tuberculosis; m, caseonecrotic granuloma(s)
seen upon microscopic examination (Mycobacterium bovis was not identified by
culture or in situ PCR and no acid-fast bacteria present in lesions); —, gross or
microscopic lesions not detected.
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bovis-infected reindeer included MPB83, MPB70, MPB59,
Acr1, ESAT-6, CFP10, and fusion proteins ESAT-6/CFP10
and Acr1/MPB83, although not all antigens were recognized at
each time point and some antigens were not recognized by sera
from each animal (Table 2; Fig. 3). For comparison, two com-
plex antigens (M. bovis PPD and MBCF) were included in the
assay and were recognized, at least at some time point, by each
M. bovis-infected animal. Responses by infected reindeer were
detected as early as 4 weeks postchallenge by MAPIA (Fig.
3B). With animal 126, MPB83 and ESAT-6 were both early
antigenic targets with reactivities to each of the single proteins
and their respective fusion proteins (Fig. 3B). As with the
ELISA and immunoblotting, the intradermal tuberculin injec-
tion for skin testing boosted responses of infected reindeer to
several antigens (Fig. 4). Serum antibodies against a limited
number of antigens (MPB83 and/or MBCF) were elicited by
skin testing in 2/4 noninoculated reindeer (animals 123 and
129) (Fig. 4A). However, the detected antibody levels in sam-
ples from the experimentally infected reindeer consistently
exceeded the detected antibody levels in samples from the two
responding noninoculated reindeer (Fig. 4).
Specificity of MAPIA. As indicated, responses in samples
from 2/4 noninoculated reindeer after the skin test were de-
tected, indicating prior sensitivity to cross-reactive antigens. To
evaluate the specificity of MAPIA, samples from noninfected
reindeer were evaluated. These samples included sera ob-
tained from reindeer in the infected group (n  11) and the
noninoculated group (n  4) at the preinoculation time point
as well as samples collected from 19 reindeer that were part of
another study. Serum antibodies against a limited number of
antigens (5/34 responded to MPB83, 2/34 responded to
ESAT-6, and 1/34 responded to MBCF) were detected and
indicative of relative specificities of 85%, 91%, and 97% for
MPB83, ESAT-6, and MBCF, respectively. Further studies to
evaluate a larger sample size (i.e., 200 reindeer serum sam-
ples) from a wide range of locations (i.e., Alaska to Tennessee)
within the United States to better estimate the specificity of
MAPIA are under way.
Association of antibody responses with pathology and bac-
teriology findings. Individual serological responses character-
ized by MAPIA appeared to correlate with pathological and
bacteriologic results. To provide this comparison, infected re-
indeer were divided into three subgroups, strong, moderate,
and weak antibody reactors, based on magnitude of the hu-
moral responses and number of antigens recognized in MAPIA
(Table 3). Additionally, MAPIA and pathology scores were
calculated based upon MAPIA band intensities/numbers and
necropsy findings, respectively. By use of linear correlation
analysis, a positive correlation between MAPIA and pathology
scores was detected (r 0.68; P 0.02) (Table 3). All infected
animals had positive histopathology results (i.e., presence of
granulomatous lesions with acid-fast organisms present), and
most of them had gross lesions consistent with TB found in at
least one tissue specimen. Each subgroup of antibody respond-
ers had one animal without gross lesions. Among the strong
antibody responders, animal 128 did not have gross lesions;
however, this animal was euthanized 7 months postinfection,
or 6 months earlier than the other infected reindeer. Further,
M. bovis culture was recovered from tissues of 3/3 strong an-
tibody responders, 0/5 moderate antibody responders, and 1/3
weak antibody responders. Intriguingly, there were only two
animals with M. bovis strains isolated from the lungs, and both
were found among the group of strong antibody responders
(i.e., animals 121 and 128). Also, the subgroups clearly differed
by extent of lesions and M. bovis replication in various tissues
(Table 3) so that the strong antibody responders had a greater
number of tissues with lesions and/or M. bovis than did the
other two subgroups.
Antibody responses and cell-mediated immunity. The sero-
logical findings obtained for each animal in the present study
were compared with skin test results and gamma interferon
FIG. 2. Preparative immunoblots of M. bovis strain 95-1315 WCS
antigen probed with sera from a reindeer experimentally infected with
M. bovis. Molecular mass markers are indicated in the left margin (in
kDa) and weeks postinfection in the lower margin. Arrows in the lower
margin indicate time points when purified protein derivatives were
injected for skin testing (CCT). Symbols in the lower left margin refer
to sera from known noninfected () and infected () white-tailed
deer used as controls for the assay. Numbers in the lower margin refer
to weeks relative to infection. Immunoblots were performed on sam-
ples from each reindeer at all time points indicated. Responses pre-
sented in this figure are representative of 10/11 of the infected rein-
deer. One infected reindeer (animal 125) had only minimal responses
detectable by immunoblot analysis.
TABLE 2. Rates of antibody responses to protein antigens detected
by MAPIA in reindeer infected with Mycobacterium bovis
Antigen No. of reactors
a
(n  11)
Sensitivity
(%)
MPB83 11 100
Acr1/MPB83 11 100
MPB70 9 82
MPB59 6 55
Acr1 5 45
ESAT-6 4 36
CFP10/ESAT-6 3 27
CFP10 1 9
38-kDa antigen 0 0
MPB64 0 0
MBCF 11 100
PPDbb 11 100
a Responses are indicative of rates of antigen recognition for each animal
measured at various time points postinfection.
b PPDb, M. bovis purified protein derivative.
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(IFN-) responses that are described in detail elsewhere (23,
35). All 11 infected reindeer tested positive by CCT (APHIS
Form VS-6-22D) for the interpretation of CCT for bison, cat-
tle, and cervidae, using either possible interpretation (23), per-
formed 3 and 8 months after M. bovis inoculation. No corre-
lation between the skin test reactions obtained with M. bovis
PPD and the levels of serum immunoglobulin responses de-
tected by ELISA or MAPIA was found. In particular, at 3
months postinfection, the strongest MAPIA responders (ani-
mals 121, 126, and 128) produced skin test reactions (changes
FIG. 3. Antibody responses to recombinant antigens detected by MAPIA in reindeer experimentally infected with M. bovis. Arrows in the upper
margin indicate time points when purified protein derivatives were injected for skin testing (CCT). Antigens printed are shown in the right margin.
Strips represent different time points during infection when serum samples were collected (shown in weeks in the lower margin). Representative
responses by two different M. bovis-infected animals, animal 120 (A) and animal 126 (B), are provided to demonstrate the variability in antigen
recognition patterns.
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in skin thickness) ranging from 17.5 mm to 24.9 mm, while the
weakest MAPIA responders (animals 125, 127, and 136) pro-
duced skin test reactions ranging from 12.9 mm to 19.3 mm,
demonstrating no significant difference between the extreme
subgroups. Further, the weakest CCT reactor, animal 135 (3.0
mm), and the strongest CCT reactor, animal 131 (25.0 mm),
had essentially the same magnitude of serological response
(Fig. 4). Similarly, there was no correlation between humoral
responses and in vitro IFN- production to M. bovis PPD
stimulation (data not shown). Interestingly, animal 126, the
only strong and early ESAT-6 antibody responder (Fig. 3), did
not have a prominent in vitro IFN- response to this antigen.
FIG. 4. Effects of injection of PPDs for skin testing on antibody responses (as measured by MAPIA) by noninfected (A) and infected
(B) reindeer to M. bovis antigens. Reindeer were injected with PPDs for skin testing 3 months after challenge with M. bovis and sera collected at
indicated time points for analysis of antibody. Numbers in the upper margins indicate animal identification numbers. Numbers in lower margins
indicate weeks relative to skin test. Antigens are indicated in the right margin.
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Instead, the highest levels of IFN- under ESAT-6 stimulation
were produced by animal 120, which showed no antibody re-
sponse against this antigen throughout the course of infection
(Fig. 3).
DISCUSSION
The present study demonstrates that experimental infection
of reindeer with M. bovis elicits antibody responses detectable
by several immunoassays using various mycobacterial antigens.
It is the first study, as far as we know, to evaluate antibody
responses and antigen recognition patterns by reindeer to M.
bovis infection. In MAPIA, the most frequently recognized
proteins were MPB83, MPB70, and MPB59. Other antigens,
including ESAT-6 and CFP10, had moderate individual sero-
reactivity (36% and 9%, respectively) and potential for detec-
tion of early infection (reindeer 126) (Fig. 3B). Sera from two
of four noninoculated reindeer exhibited weak reactivities to
mycobacterial antigens, and these responses correlated with
pathological findings. Lesions found in lung-associated lymph
nodes from these two reindeer were granulomatous with no
isolation of M. bovis and no detection of acid-fast bacteria.
Infection with M. tuberculosis complex mycobacteria was fur-
ther ruled out by in situ PCR for IS6110. In a concurrent study
evaluating cellular immune responses, each of these two rein-
deer had intermittent IFN- responses to M. bovis PPD con-
sidered positive, yet these two reindeer did not exhibit positive
IFN- responses to rESAT6/CFP10 (35). Interestingly, IFN-
responses to M. bovis PPD by these two reindeer exceeded
concurrent responses to M. avium PPD. One of the two non-
infected reindeer exhibiting positive antibody responses also
tested positive by skin test (second CCT only) (23). It should
be noted, however, that both IFN- and skin test responses to
M. bovis PPD by infected reindeer greatly exceeded those of
noninfected reindeer (23, 35). Together, these findings indi-
cate that lymphocytes (both B and T cells) from nontubercu-
lous reindeer react to certain antigens within M. bovis PPD,
likely due to exposure to cross-reactive epitopes of other non-
tuberculous species of bacteria, highlighting the unique re-
sponse of this host to mycobacterial antigens.
Reindeer are susceptible to infection with other mycobacte-
rial agents, such as M. avium subsp. paratuberculosis and My-
cobacterium kansasii (13). Lesions in M. kansasii-infected re-
indeer closely resemble those seen from M. bovis-inoculated
reindeer (13). Antigens traditionally considered specific for the
M. tuberculosis complex (e.g., ESAT-6, CFP10, and MPB83)
are also produced by M. kansasii and have been shown to elicit
an immune response in M. kansasii-sensitized/infected cattle,
humans, nonhuman primates, and guinea pigs (6, 7, 8, 9, 30;
W. R. Waters and K. P. Lyashchenko, unpublished observa-
tions). In the present study, the only other mycobacterium
isolated was Mycobacterium duvalii from a sample of kidney.
Mycobacterium duvalii is commonly associated with soil and is
not known to be a pathogen of animals. While this is specula-
tion, it is likely that responses detected by noninoculated re-
indeer resulted from infection/sensitization with nontubercu-
lous mycobacteria or closely related bacteria, resulting in a
cross-reactive response.
In earlier studies, LAM has proven useful in antibody-based
tests of mycobacterial infections in cattle and white-tailed deer
and provides a tool to objectively evaluate antibody response
kinetics upon experimental inoculation (5, 12, 14, 25–28, 31,
32, 34). However, this antigen is broadly cross-reactive with
nontuberculous mycobacteria. The use of purified proteins
could improve the specificities of antibody-based TB tests, but
the sensitivities might be insufficient. Previous serological stud-
ies on tuberculous cattle, Eurasian badgers (Meles meles), and
TABLE 3. Association of the tuberculin-boosted antibody responses to M. bovis antigens with pathology/bacteriology findings in
experimentally infected reindeer
Animal
Results for antibodies in MAPIA Pathology and bacteriology results
Band
intensitya
No. of
bands
MAPIA
scoreb Gross lesions
Culture from
tissues
No. of positive
tissuesc
Pathology
scored
121  4 7 Positive Positive 3 5
126  6 9 Positive Positive 5 7
128e  4 7 Positive Positive 4 6
120  4 6 Negative Negative 1 1
131  4 6 Negative Negative 1 1
133  4 6 Negative Negative 1 1
134  3 5 Negative Negative 3 3
135  3 5 Negative Negative 0 0
125 / 2 2.5 Negative Negative 2 2
127  4 5 Positive Positive 1 3
136  3 4 Negative Negative 0 0
a Magnitude of antibody response to most seroreactive antigen(s) detected by MAPIA 2 to 4 weeks after skin testing performed 3 months postinfection was scored
visually as strong (), moderate (), weak (), or very weak (/).
b MAPIA score is the band intensity (e.g.,  represents 3 and / represents 0.5) plus number of bands.
c At necropsy (13 months postinfection), 15 tissue specimens, including tonsil, lung, spleen, liver, kidney, and 10 different lymph nodes, were examined for gross
lesions consistent with tuberculosis and histopathology (caseonecrotic granuloma with acid-fast bacilli); the tissues were also used to isolate M. bovis by bacteriologic
culture; disease status was confirmed for all 11 infected reindeer by positive histopathology findings in one or more tissue specimens (not shown). Numbers of tissues
with positive gross pathology and/or bacteriology results are shown.
d The pathology score is the value for gross lesions plus the value for culture from tissues plus the number of positive tissues. Positive and negative findings were
assigned values of 1 and 0, respectively. Pearson’s correlation coefficient was 0.68 (P  0.02) for the comparison of MAPIA scores to pathology scores.
e Euthanized 7 months postinfection due to complications unrelated to M. bovis inoculation.
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white-tailed deer have demonstrated that antibody responses
of these species to M. bovis are characterized by recognition of
variable patterns of multiple proteins (1, 10, 17, 18, 20, 34).
MPB70 and MPB83 proteins are predominantly reactive in
cattle, whereas MPB83 is the most serodominant antigen in
white-tailed deer and, particularly, in European badgers (4, 10,
11, 20, 34). Sera from M. bovis-infected cattle, white-tailed
deer, and badgers also react with other specific proteins (e.g.,
ESAT-6 and CFP10), but the set of most frequently recognized
antigens may vary among the host species (10, 17, 18, 20, 34).
Thus, it is crucial to determine antigen recognition patterns
over the course of M. bovis infection for each of the various
hosts. Utilizing several of the most immunodominant antigens
as defined for reindeer in the present study, a simple serolog-
ical test can be developed using advanced immunoassay tech-
nologies, such as the lateral-flow format suitable for rapid field
testing (10).
The present study also demonstrated that humoral re-
sponses did not correlate with T-cell immunity of infected
reindeer. However, the extent of pathology developed in indi-
viduals correlated well with the magnitude of their antibody
responses. These findings are in agreement with recent obser-
vations on antibody responses of M. bovis-infected cattle and
white-tailed deer (19, 34, 36), thus indicating that the serolog-
ical approach may have not only diagnostic value but also
prognostic potential. As is the case with cattle (36), it appears
that antibody levels are positively correlated with disease pro-
gression and may be indicative of host susceptibility among
cervid species. Disease progression in white-tailed deer is more
rapid than that in reindeer (23); likewise, antibody responses
by M. bovis-infected white-tailed deer (34) are more vigorous
and develop more rapidly than those of reindeer (present
study). Specific IFN- responses by inoculated reindeer were
robust, detected early, and maintained throughout the dura-
tion of the study (35), indicative of a prominent cellular re-
sponse. The results indicate that antibody-based tests provide
a convenient and inexpensive antemortem tool to evaluate
disease progression (positive correlation with antibody) and/or
protective immunity (negative correlation with antibody) in
animals used in trials for new vaccines. To serve this purpose,
the serological assays must differentiate antibody responses
produced against vaccine antigens from those induced by M.
bovis infection.
Studies with cattle and white-tailed deer have also demon-
strated that antibody responses of infected animals can be
boosted significantly by the intradermal tuberculin injection
administered for routine skin testing (11, 15). These anamnes-
tic responses are mediated mostly by IgG1 in cattle and may
involve multiple antigens (16, 17). In the present study, we
found a similar boosting effect of tuberculin skin testing on
humoral responses to M. bovis in experimentally infected re-
indeer. The sharply elevated antibody levels appeared 2 weeks
after skin testing and gradually declined a few weeks later,
suggesting that B-cell memory primed by M. bovis inoculation
played a role. This phenomenon requires further investigation
and, if proven diagnostically specific, may be a powerful ap-
proach to enhance the potential of TB serodiagnosis. For in-
stance, a serological TB test could be used in conjunction with
standard skin testing procedures (i.e., as a complementary or
confirmatory test).
Ultimately, it would be advantageous to develop and imple-
ment a stand-alone blood-based assay for TB surveillance of
reindeer and other species. Another option is for antibody-
based tests to be used as confirmatory tests performed several
weeks after skin testing procedures. This approach could prove
useful in decreasing the number of reindeer slaughtered due to
false-positive skin test reactions to the complex cocktail of
antigens contained within M. bovis PPD. Future studies will
determine the specificity of such a test, particularly given the
likelihood of confounding cross-reactive responses probably
elicited by exposure to nontuberculous mycobacteria.
ACKNOWLEDGMENTS
USDA, APHIS, in part, provided funds for these studies.
We thank Peter Lasley, Rebecca Lyon, Jessica Pollock, and Shelly
Zimmerman for excellent technical support. We also thank Richard
Auwerda, Gary Buck, Doug Ewing, Andrew Gibson, Don Hackbarth,
Todd Holtz, Terry Krausman, David Panthen, Brian Pottebaum, Don
Robinson, Jay Steffen, Johann Thiel, Wayne Varland, and Larry
Wright for excellent animal care.
REFERENCES
1. Amadori, M., K. P. Lyashchenko, M. L. Gennaro, J. M. Pollock, and I.
Zerbini. 2002. Use of recombinant proteins in antibody tests for bovine
tuberculosis. Vet. Microbiol. 85:379–389.
2. Bannantine, J., and J. R. Stabel. 2000. HspX is present within Mycobacte-
rium paratuberculosis-infected macrophages and is recognized by sera from
some infected cattle. Vet. Microbiol. 76:343–358.
3. Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V.
Gordon, et al. 1998. Deciphering the biology of Mycobacterium tuberculosis
from the complete genome sequence. Nature 393:537–544.
4. Fifis, T., C. Costopoulos, L. A. Corner, and P. R. Wood. 1992. Serological
reactivity to Mycobacterium bovis protein antigens in cattle. Vet. Microbiol.
30:343–354.
5. Gaborick, C., M. D. Salman, R. P. Ellis, and J. Triantis. 1996. Evaluation of
a five-antigen ELISA for diagnosis of tuberculosis in cattle and cervidae.
J. Am. Vet. Med. Assoc. 209:962–966.
6. Geluk, A., K. E. Van Meijgaarden, K. L. Franken, B. Wieles, S. M. Arend,
W. R. Faber, B. Naafs, and T. H. Ottenhoff. 2004. Immunological crossre-
activity of the Mycobacterium leprae CFP-10 with its homologue in Mycobac-
terium tuberculosis. Scand. J. Immunol. 59:66–70.
7. Geluk, A., K. E. van Meijgaarden, K. L. Franken, Y. W. Subronto, B. Wieles,
S. M. Arend, E. P. Sampaio, T. de Boer, W. R. Faber, B. Naafs, and T. H.
Ottenhoff. 2002. Identification and characterization of the ESAT-6 homo-
logue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium
tuberculosis. Infect. Immun. 70:2544–2548.
8. Gey van Pittius, N. C., R. M. Warren, and P. D. van Helden. 2002. ESAT-6
and CFP-10: what is the diagnosis? Infect. Immun. 70:6509–6511.
9. Gey Van Pittius, N. C., J. Gamieldien, W. Hide, G. D. Brown, R. J. Siezen,
and A. D. Beyers. 2001. The ESAT-6 gene cluster of Mycobacterium tuber-
culosis and other high GC Gram-positive bacteria. Genome Biol. 2:0044–
0048.
10. Greenwald, R., J. Esfandiari, S. Lesellier, R. Houghton, J. Pollock, C. Aa-
gaard, P. Andersen, R. G. Hewinson, M. Chambers, and K. Lyashchenko.
2003. Improved serodetection of Mycobacterium bovis infection in badgers
(Meles meles) using multiantigen test formats. Diagn. Microbiol. Infect. Dis.
46:197–203.
11. Harboe, M., H. G. Wiker, J. R. Duncan, M. M. Garcia, T. W. Dukes, B. W.
Brooks, C. Turcotte, and S. Nagai. 1990. Protein G-based enzyme-linked
immunosorbent assay for anti-MPB70 antibodies in bovine tuberculosis.
J. Clin. Microbiol. 28:913–921.
12. Jark, U., I. Ringena, B. Franz, G. F. Gerlach, M. Beyerbach, and B. Franz.
1997. Development of an ELISA technique for serodiagnosis of bovine
paratuberculosis. Vet. Microbiol. 51:189–198.
13. Kiupel, M., H. Simmon, D. Berry, and C. Bolin. 2003. Mycobacterium kan-
sasii in reindeer (Rangifer tarandus), p. 120. In Proceedings of the American
Association of Veterinary Laboratory Diagnosticians.
14. Koets, A. P., V. P. Rutten, M. de Boer, D. Bakker, P. Valentin-Weigand, and
W. van Eden. 2001. Differential changes in heat shock protein-, lipoarabi-
nomannan-, and purified protein derivative-specific immunoglobulin G1 and
G2 isotype responses during bovine Mycobacterium avium subsp. paratuber-
culosis infection. Infect. Immun. 69:1492–1498.
15. Lightbody, K. A., R. A. Skuce, S. D. Neill, and J. M. Pollock. 1998. Myco-
bacterial antigen-specific antibody responses in bovine tuberculosis: an
ELISA with potential to confirm disease status. Vet. Rec. 142:295–300.
734 WATERS ET AL. CLIN. DIAGN. LAB. IMMUNOL.
 at D
igiTop -- USDA's Digital Desktop Library on April 12, 2010 
cdli.highwire.org
D
ow
nloaded from
 
16. Lightbody, K. A., J. McNair, S. D. Neill, and J. M. Pollock. 2000. IgG isotype
antibody responses to epitopes of the Mycobacterium bovis protein MPB70 in
immunised and in tuberculin skin test-reactor cattle. Vet. Microbiol. 75:177–
188.
17. Lyashchenko, K., A. O. Whelan, R. Greenwald, J. M. Pollock, P. Andersen,
R. G. Hewinson, and H. M. Vordermeier. 2004. Association of tuberculin-
boosted antibody responses with pathology and cell-mediated immunity in
cattle vaccinated with Mycobacterium bovis BCG and infected with M. bovis.
Infect. Immun. 72:2462–2467.
18. Lyashchenko, K. P., J. M. Pollock, R. Colangeli, and M. L. Gennaro. 1998.
Diversity of antigen recognition by serum antibodies in experimental bovine
tuberculosis. Infect. Immun. 66:5344–5349.
19. Lyashchenko, K. P., M. Singh, R. Colangeli, and M. L. Gennaro. 2000. A
multi-antigen print immunoassay for the development of serological diag-
nosis of infectious diseases. J. Immunol. Methods 242:91–100.
20. McNair, J., D. M. Corbett, R. M. Girvin, D. P. Mackie, and J. M. Pollock.
2001. Characterization of the early antibody response in bovine tuberculosis:
MPB83 is an early target with diagnostic potential. Scand. J. Immunol.
53:365–371.
21. Palmer, M. V., D. L. Whipple, and S. C. Olsen. 1999. Development of a
model of natural infection with Mycobacterium bovis in white-tailed deer. J.
Wildl. Dis. 35:450–457.
22. Palmer, M. V., D. L. Whipple, and W. R. Waters. 2001. Tuberculin skin
testing in white-tailed deer (Odocoileus virginianus). J. Vet. Diagn. Investig.
13:530–533.
23. Palmer, M. V., W. R. Waters, T. C. Thacker, and B. V. Thomsen. Experi-
mental infection of reindeer (Rangifer tarandus) with Mycobacterium bovis.
Submitted for publication.
24. Schmitt, S. M., S. D. Fitzgerald, T. M. Cooley, C. S. Bruning-Fann, L.
Sullivan, D. Berry, T. Carlson, R. B. Minnis, J. B. Payeur, and J. Sikarskie.
1997. Bovine tuberculosis in free-ranging white-tailed deer from Michigan. J.
Wildl. Dis. 33:749–758.
25. Sugden, E. A., B. S. Samagh, D. R. Bundle, and J. R. Duncan. 1987. Li-
poarabinomannan and lipid-free arabinomannan antigens of Mycobacterium
paratuberculosis. Infect. Immun. 55:762–770.
26. Sugden, E. A., A. H. Corner, B. S. Samagh, B. W. Brooks, C. Turcotte, K. H.
Nielsen, R. B. Stewart, and J. R. Duncan. 1989. Serodiagnosis of ovine
paratuberculosis, using lipoarabinomannan in an enzyme-linked immunosor-
bent assay. Am. J. Vet. Res. 6:850–854.
27. Sugden, E. A., K. Stilwell, E. B. Rohonczy, and P. Martineau. 1997. Com-
petitive and indirect enzyme-linked immunosorbent assays for Mycobacte-
rium bovis infections based on MPB70 and lipoarabinomannan antigens.
Can. J. Vet. Res. 61:8–14.
28. Sugden, E. A., K. Stilwell, and A. Michaelides. 1997. A comparison of
lipoarabinomannan with other antigens used in the absorbed enzyme immu-
noassays for the serological detection of cattle infected with Mycobacterium
paratuberculosis. J. Vet. Diagn. Investig. 9:413–417.
29. United States Department of Agriculture. 1999. Bovine tuberculosis eradi-
cation uniform methods and rules. APHIS 91-45-011. U.S. Government
Printing Office, Washington, D.C.
30. Vosloo, W., P. Tippoo, J. E. Hughes, N. Harriman, M. Emms, D. W. Beatty,
H. Zappe, and L. M. Steyn. 1997. Characterisation of a lipoprotein in My-
cobacterium bovis (BCG) with sequence similarity to the secreted protein
MPB70. Gene 188:123–128.
31. Waters, W. R., M. V. Palmer, and D. L. Whipple. 2002. Mycobacterium
bovis-infected white-tailed deer (Odocoileus virginianus): detection of immu-
noglobulin specific to crude mycobacterial antigens by ELISA. J. Vet. Diag.
Investig. 14:470–475.
32. Waters, W. R., J. M. Miller, M. V. Palmer, J. R. Stabel, D. E. Jones, K. A.
Koistinen, E. M. Steadham, M. J. Hamilton, W. C. Davis, and J. P. Ban-
nantine. 2003. Early induction of a humoral and cellular immune response
during experimental Mycobacterium avium subsp. paratuberculosis infection
of calves. Infect. Immun. 71:5130–5138.
33. Waters, W. R., M. V. Palmer, S. C. Olsen, R. E. Sacco, and D. L. Whipple.
2003. Immune responses of elk to Mycobacterium bovis bacille Calmette
Guerin vaccination. Vaccine 21:1518–1526.
34. Waters, W. R., M. V. Palmer, J. P. Bannantine, D. L. Whipple, R. Greenwald,
J. Esfandiari, P. Andersen, J. McNair, J. M. Pollock, and K. P. Lyashchenko.
2004. Antigen recognition by serum antibodies in white-tailed deer
(Odocoileus virginianus) experimentally infected with Mycobacterium bovis.
Clin. Diagn. Lab. Immunol. 11:849–855.
35. Waters, W. R., M. V. Palmer, R. E. Slaughter, S. L. Jones, J. E. Pitzer, and
F. C. Minion. A blood-based gamma interferon assay for the detection of
Mycobacterium bovis-infected reindeer (Rangifer tarandus). Submitted for
publication.
36. Welsh, M. D., R. T. Cunningham, D. M. Corbett, R. M. Girvin, J. McNair,
R. A. Skuce, D. G. Bryson, and J. M. Pollock. 2005. Influence of pathological
progression on the balance between cellular and humoral immune responses
in bovine tuberculosis. Immunology 114:101–111.
VOL. 12, 2005 ANTIBODY RESPONSES IN M. BOVIS-INFECTED REINDEER 735
 at D
igiTop -- USDA's Digital Desktop Library on April 12, 2010 
cdli.highwire.org
D
ow
nloaded from
 
